is retatrutide the same as mounjaro vs Tirzepatide: 28.7% vs 22.5% (2026) Mounjaro

The anticipated price reductions from Medicare negotiations may influence employer-sponsored health plans to adjust their coverage policies for GLP-1s

Tirzepatide is a dual-acting medication that targets two specific hormone receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)

A balanced approach combining moderate cardio, resistance training, and increased daily movement produces the best outcomes during plateaus

The most common treatment-emergent AEs were gastrointestinal in nature and mostly mild in severity

Levels peak 45-90 minutes later, then decline over several hours